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Abstract 
Background: Immunological test systems for diagnostics of type I hypersensitivity involve the following types of 
antigens: whole allergen extracts, individual highly purified proteins and their recombinant analogues. The goal of this 
study was to compare the results obtained with whole allergen extracts (birch pollen, cat dander, and timothy grass 
pollen) and their respective recombinant proteins in biochip-based immunoassay.
Methods: Multiplex fluorescent immunoassay of 139 patients’ blood serum samples was carried out using biological 
microchips (biochips). sIgE concentrations for the chosen allergens and their recombinant components were meas-
ured. ROC analysis was used for comparison of the results and determination of diagnostic accuracy.
Results: The results for the birch pollen extract and its recombinant allergens have shown that the diagnostic accu-
racy of the methods utilizing the whole allergen extract, its major component Bet v 1 and the combination of major 
and minor components (Bet v 1 and Bet v 2) was the same. Values for diagnostic accuracy for the cat dander extract 
and its major recombinant component Fel d 1 were equal. In contrast with birch pollen and cat dander allergens, 
using of recombinant components of timothy grass pollen (Phl p 1, Phl p 5, Phl p 7 and Phl p 12) did not allow reach-
ing the diagnostic accuracy of using natural extract.
Conclusions: Multiplex analysis of samples obtained from patients with allergy to birch pollen and cat dander using 
biological microchips has shown that comparable accuracy was observed for the assay with natural extracts and 
recombinant allergens. In the case of timothy grass allergen, using the recombinant components may be insufficient.
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Background
Immunological test systems for diagnostics of type I 
hypersensitivity currently involve whole allergen extracts, 
highly purified allergens from the extracts, and their 
recombinant analogues obtained by gene engineering 
techniques. The majority of test systems use extracts and 
allergen mixtures.
Extracts are heterogeneous protein mixtures isolated 
from natural materials containing allergenic and non-
allergenic material. They allow estimating the reactiv-
ity of a patient’s serum toward all potentially allergenic 
components. Furthermore, allergen extracts contain both 
species-specific proteins and components with epitopes 
demonstrating high cross-reactivity with proteins from 
other origins. This complicates the identification of the 
primary allergy source [1]. Moreover, the standardization 
of extracts composition is yet another application prob-
lem. It has been shown in a number of studies that aller-
gen extracts produced by number of manufacturers differ 
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considerably in composition and activity [2, 3], leading to 
discrepancy between analysis results in various test sys-
tems [4].
In vitro allergy diagnostics with standardized recom-
binant allergens and highly purified components of aller-
gen extracts enables getting more reproducible results. 
It should be noted that the current number of recom-
binant allergens does not cover the entire spectrum of 
potentially allergenic proteins present in extracts. This 
is why the use of only individual protein components is 
not recommended to identify the allergy source, because 
it may give a false-negative result in the case of immune 
response to a protein that is not included in that range. 
Therefore allergy diagnostics is mostly carried out taking 
into account clinical history, results of skin tests and/or 
measurement of sIgE to allergen extracts, whereas molec-
ular-based allergy diagnostics employing individual aller-
gen components is applied for polysensitized patients [5, 
6] in order to identify the main sensitizing component, 
for example, for subsequent allergen specific immuno-
therapy (ASIT) [7, 8] and for prediction and monitoring 
of treatment efficiency [9].
Some cases showed that analysis with recombinant 
allergens increased the diagnostics accuracy [10, 11]. 
Currently, the most widely used test system based only 
on recombinant allergens is ImmunoCAP ISAC®, manu-
factured by Phadia (at present trademark of Thermo Fis-
cher Scientific Inc.).
Though individual allergen proteins have been used in 
studies on the efficacy of diagnostics with recombinant 
allergens since the 1990s [12], there are a few exam-
ples of simultaneous multiplex analysis of sIgE both to 
whole allergen extracts and their recombinant proteins. 
It seems that the biological microchip is the most con-
venient instrument for simultaneous analyzing of sIgE to 
both individual molecules whole allergen extracts in one 
serum sample during one assay. The purpose of this work 
was to compare the diagnostic accuracy of the method 
for detection of type I hypersensitivity using whole aller-
gen extracts of birch pollen, cat dander and timothy grass 
pollen (diagnostically significant in central Russia) and 
their corresponding recombinant proteins on the biologi-
cal microchips. Comparison of the diagnostic accuracy 
was made using receiver operating curve (ROC) analysis.
Methods
Patients
The study was carried out using patients’ blood serum 
samples provided by the Federal State Budgetary Institu-
tion Polyclinic #1 of the Business Administration for the 
President of the Russian Federation. Primary selection of 
the patients was based on the presence of allergy symp-
toms in the anamnesis: seasonal allergic rhinitis during 
early spring or summer period as well as year-round rhi-
nitis remissive in outdoor conditions.
Sera from patients demonstrating positive skin prick 
test (SPT) (reaction  >2  mm wheal diameter at least to 
one of the extracts: birch pollen, timothy grass pollen or 
cat dander) were chosen for the study. Sera from patients 
exhibiting positive SPT to the allergen were approved as 
positive to this allergen. Sera from patients demonstrat-
ing negative SPT to the allergen (reaction <2 mm wheal 
diameter) were approved as negative to this allergen. SPT 
was performed using salt aqueous extracts, histamine 
dihydrochloride 0.1  % as a positive control and NaCl 
0.9 % as a negative control.
Totally, sera from 139 patients were chosen: 56, 73, and 
33 of them were sensitized to birch pollen, cat dander 
and timothy grass pollen, respectively. The data of the 
patients’ sera were analyzed anonymously.
Analysis of blood sera on biochips
Patients’ blood sera were analyzed by the multiplex fluo-
rescent immunoassay method on biological microchips/
biochips (EIMB RAS).The biochip manufacturing and 
procedure of biochip-based immunoassay of allergen-
specific IgE have been described previously [13, 14]. Bio-
chip was the set of semispherical hydrogel elements of 
0.1  nL containing the following immobilized antigens: 
birch pollen, recombinant allergens of birch pollen—
Bet v 1 and Bet v 2; cat dander, recombinant allergen of 
cat dander—Fel  d  1; timothy grass pollen, recombinant 
allergens of timothy grass pollen—Phl p 1, Phl p 5, Phl p 7 
and Phl p 12 (Fig. 1).
Biochip-based assay allows analyzing of sIgE in the 
range from 0.15 to 100  IU/ml [12]. We used the con-
centration 0.35  IU/ml as the cut-off for distinguishing 
between positive and negative results according to the 
WHO recommendation.
Statistical analysis
ROC analysis was performed to estimate the diagnostic 
accuracy of using allergen extracts and their recombi-
nant proteins. The ROC curves were built and the areas 
under the curve (AUC) were calculated using MedCalc 
program, version 15.2.2 [15, 16].When constructing ROC 
curves for a mixture of recombinant proteins, the result 
was considered as positive if at least one of the proteins 
showed positive signal for a chosen cut-off.
Results and discussion
In this study we analyzed 139 blood serum samples from 
patients with allergy to birch pollen (56 cases), cat dander 
(73 cases) or timothy grass pollen (33 cases). These aller-
gens are most widespread and diagnostically significant 
in central Russia. For each allergen we determined the 
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level of sIgE to the natural extracts and to their recom-
binant proteins: Bet v 1, Bet v 2, Phl p 1, Phl p 5, Phl p 7, 
Phl  p  12, Fel  d  1. Fig.  1 shows the biochip structure (a) 
and the example of fluorescent image after the immu-
noassay (b) Data were analyzed with ROC analysis. The 
results are presented in Table  1 and Fig.  2. Statistical 
analysis of the results for diagnostic accuracy of using the 
natural birch pollen extract and its recombinant com-
ponents has shown that the AUC was 0.95 both for the 
extract and for its major recombinant protein Bet v 1 or 
0.83 for the minor component profilin Bet  v  2. For the 
combination Bet v 1 + Bet v 2 the AUC was the same and 
equaled to 0.95.
Analysis of diagnostic accuracy of using the cat dander 
allergen has shown that the AUC both for the extract and 
for the recombinant Fel d 1 was the same and equaled to 
0.76.
The results obtained for the birch and cat allergens 
are in accordance with available literature data concern-
ing the frequency of occurrence of immune response to 
various allergenic components. Sensitization to Bet  v  1 
as major allergen occurs in a considerable fraction of 
patients who have allergy to birch pollen (60–90 %) [17], 
while as little as 12  % of patients have sensitization to 
other recombinant components (Bet v 2, Bet v 4, Bet v 6, 
Bet  v  8, etc.) [18]. According to various estimates, sen-
sitization to Fel  d  1 occurs in 80–95  % of patients with 
hypersensitivity to cat dander, which results in a high effi-
ciency of the diagnostic test employing this recombinant 
protein. From the data obtained it can be assumed that 
for diagnostics purposes allergen extracts can be replaced 
by a combination of the corresponding recombinant 
components in case of birch pollen or by the major 
recombinant protein Fel  d  1 for cat dander. However it 
should be noted that both false positive and false nega-
tive results may be obtained in this case. For example, 
interaction of Fel  d  1 allergen with IgE specific to dog 
dander [19] is observed in 25 % of patients with allergy to 
dog dander. On the other hand, a patient may show sensi-
tization to minor allergen components that only occur in 
whole allergen extracts. In these cases, the usage of only 
recombinant allergens could give false negative results.
To estimate the diagnostic accuracy of analysis in case 
of allergy to timothy grass, we used natural extract and 
four different recombinant proteins: Phl p 1, Phl p 5 and 
Phl p 7, Phl p 12. The obtained data show that the AUC 
for the extract was 0.83, for Phl p 1 and combination of 
Fig. 1 a Schematic arrangement of immobilized allergen extracts, their recombinant proteins, and marker spots (М) on biological microchips. Each 
antigen was immobilized in quadruplicate. Non-specific binding was monitored using spots that contain no proteins (empty gel). b An example of 
fluorescent image of a biochip after immunoassay of a blood serum sample from a patient with allergy to birch pollen and cat dander
Table 1 Comparison of  ROC analysis results for  methods 
of  identification of  type I hypersensitivity using allergen 
extracts, recombinant components, and recombinant com-
ponents groups
a For the recombinant proteins groups the sample was considered positive if at 
least one of the proteins showed positive result for the current cut-off
Antigen AUC P value
Birch pollen (Positive: 56, Negative: 36)
 Natural extract of birch pollen 0.95 <0.0001
 Bet v 1 0.95 <0.0001
 Bet v 2 0.83 <0.0001
 Bet v 1 + Bet v 2a 0.95 <0.0001
Cat dander (Positive: 73, Negative: 66)
 Natural extract of cat dander 0.76 <0.0001
 Fel d 1 0.76 <0.0001
Timothy grass pollen (Positive: 33, Negative: 59)
 Natural extract of timothy grass pollen 0.83 <0.0001
 Phl p 1 0.71 <0.001
 Phl p 5 0.65 <0.02
 Phl p 7 0.65 <0.02
 Phl p 12 0.66 <0.01
 Phl p 1 + Phl p 5 0.71 <0.001
 Phl p 1 + Phl p 5 + Phl p 7 + Phl p 12a 0.74 <0.0001
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Phl p 1 and Phl p 5 was 0.71, whereas for Phl p 5, Phl p 7 
and Phl p 12 AUC ranged within 0.65–0.66. The AUC was 
0.74 for the combination of 4 recombinant components.
Phl p 1 and Phl p 5 are considered to be the major tim-
othy grass pollen components. According to literature 
data, Phl p 1 is involved in sensitization process for more 
than 90 % of the patients with timothy grass allergy  [20, 
21], so sIgE to Phl p 1 is sufficient for diagnostics of timo-
thy grass pollen allergy for Central European population 
[22]. However, according to our data, the accuracy of 
using this recombinant component is lower than using 
the extract. The addition of the major component Phl p 5, 
which occurs in up to 80 % of timothy grass pollen sensi-
tized patients, does not increase the AUC value.
The efficiency of the diagnostics with using solely 
minor cross-reactive components calcium-binding pro-
tein Phl p 7 and profilin Phl p 12 is rather poor, but their 
inclusion in the analysis along with the major proteins 
Fig. 2 Comparison of ROC curves for methods of identification of type I hypersensitivity using allergen extracts, recombinant components, and 
combinations of recombinant components. a 1-Bet v 1, 2-Bet v 2, 3-Bet v 1 and Bet v 2, 4—birch pollen extract. b 1-Fel d 1, 2—cat dander extract 
and Fel d 1, 3-cat dander extract. c 1-Phl p 1, 2-Phl p 5, 3-Phl p 7, 4-Phl p 12, 5-Phl p 1, Phl p 5, Phl p 7, Phl p 12, 6-timothy grass pollen extract
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improves AUC from 0.71 to 0.74. Thus, it can be con-
cluded that, unlike the situations with birch and cat 
allergens, the use of available recombinant proteins to 
timothy grass pollen does not allow reaching the diag-
nostic accuracy for the natural extract.
In the current work biochips were used as a research 
instrument for the comparison of diagnostic approaches 
based on natural extracts and their recombinant compo-
nents. Furthermore, after modification and validation the 
biochips could appear as practically significant method 
combining second- and third-line approaches of allergy 
diagnostics.
Conclusions
Multiplex analysis of serum samples obtained from 
patients with allergy to birch and cat dander carried 
out on biological microchips has shown that the use of 
recombinant allergens give accuracy comparable to the 
natural extracts. In the case of timothy grass, the use of 
the recombinant components may be insufficient for the 
identification of allergy source. In some cases, simulta-
neous analysis using both extracts and their individual 
protein components is preferable. This approach can be 
efficiently implemented by means of the protein biochip 
technology.
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